Table 1.
Expression of miR-624-5p and PTPRB according to patients’ clinical features
miR-624-5p expression | PTPRB expression | ||||||
---|---|---|---|---|---|---|---|
Characteristics | Number | High group | Low group | P value | High group | Low group | P value |
Age(y) | |||||||
< 18 | 29 | 14 | 15 | 0.70 | 15 | 14 | 0.96 |
≥ 18 | 21 | 9 | 12 | 11 | 10 | ||
Gender | |||||||
Female | 23 | 13 | 10 | 0.39 | 12 | 11 | 0.61 |
Male | 27 | 12 | 15 | 16 | 11 | ||
Location | |||||||
Femur/Tibia | 39 | 18 | 21 | 0.96 | 20 | 19 | 0.47 |
Elsewhere | 11 | 5 | 6 | 7 | 4 | ||
TNM stage | |||||||
I | 23 | 11 | 12 | 0.028a | 15 | 8 | 0.012a |
II/III | 27 | 21 | 6 | 8 | 19 | ||
Tumor size (cm) | |||||||
< 5 | 28 | 12 | 16 | 0.014a | 17 | 11 | 0.042a |
≥ 5 | 22 | 17 | 5 | 7 | 15 | ||
Lung metastasis | |||||||
Yes | 21 | 18 | 3 | 0.012a | 6 | 15 | 0.01a |
No | 29 | 15 | 14 | 19 | 10 |
aP < 0.05(Chi-square test)